Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity.

Full Abstract

OBJECTIVE:
Antidepressants that increase serotonin or norepinephrine in the brain are effective in treating depression, but there is no neuropsychological account of how these changes relieve depressive states. Cognitive theories suggest that biases in information processing lead depressed patients to make unrealistically negative judgments about themselves and the world.

METHOD:
A single dose of the noradrenergic antidepressant reboxetine or placebo was administered to 24 healthy volunteers. Effects on emotional processing were assessed through facial expression recognition, emotional categorization, and emotional memory.

RESULTS:
On the three measures, reboxetine biased perception toward positive, rather than negative, information in the absence of changes in nonemotional performance or mood.

CONCLUSIONS:
These results suggest that a single dose of an antidepressant can increase the processing of positively valenced material in nondepressed volunteers. Antidepressants may therefore work in a manner similar to that of psychological treatments that aim to redress negative biases in information processing.

Learn Faster Today Improve your study skills

Author information

Author/s: Harmer, Catherine J (CJ); Hill, Simon A (SA); Taylor, Matthew J (MJ); Cowen, Philip J (PJ); Goodwin, Guy M (GM);

Affiliation: Department of Psychiatry, Oxford University, Warneford Hospital, Oxford OX3 7JX, USA. catherine.harmer(-atsign-)psych.ox.ac.uk

Journal and publication information

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial

Journal: The American journal of psychiatry (Am J Psychiatry), published in United States. (Language: eng)

Reference: 2003-May; vol 160 (issue 5) : pp 990-2

Dates: Created 2003/05/02; Completed 2003/06/17; Revised 2006/11/15;

PMID: 12727705, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Adrenergic Uptake Inhibitors - pharmacology; therapeutic use
Adult
Affect - drug effects
Depressive Disorder - drug therapy; psychology
Discrimination (Psychology) - drug effects
Double-Blind Method
Emotions - drug effects
Facial Expression
Female
Happiness
Humans

Humans
Male
Memory - drug effects
Middle Aged
Models, Biological
Models, Psychological
Morpholines - pharmacology; therapeutic use
Negativism
Neuropharmacology
Neuropsychological Tests
Personality - classification

Associated Chemicals: Adrenergic Uptake Inhibitors (0) ; Morpholines (0) ; reboxetine (98769-81-4)

This article has not been indexed for related articles as yet, however you can still use the live related article search links below.

See 100+ related articles.